SwarmLabs replaces wet-lab experiments with virtual ones and issues auditable 10-chapter V&V reports (aligned to ASME V&V 10-2019 and the FDA CM&S outline). The scarce asset is not another model that generates hypotheses — it is honest uncertainty quantification that tells you when a prediction can be trusted, and when it cannot.
The measurement / evaluation layer of AI for Science has become strategic infrastructure — and it is exactly the layer that model-first labs are missing.
UniPat AI raised $300M at a $2.5B valuation (Alibaba led, Tencent participated) to build synthetic data and AI evaluation / benchmark design. Anthropic acquired Coefficient Bio for $400M to bring rigorous verification into its science stack. Whoever measures others' models holds the leverage.
Foundation models can now propose hypotheses. Almost none can tell you, with a computed number, how confident a result is or where the model stops being valid. SwarmLabs is that missing layer: GP surrogates + coverage-audited intervals + an explicit out-of-distribution guard.
Every scenario produces an archived 10-chapter V&V report with R², single-sided coverage, variance-calibration κ, and a reproducibility manifest (seeds / bounds / re-run command) — exportable to HTML, JSON and DOCX. Chat products cannot archive a defensible audit trail.
Where the field says "Prompt-to-Drug", the gate is the prompt-to-validation step that hunch-driven pipelines skip. Ours runs daily: a signal→candidate→verify→promote→effect flywheel where every promotion clears the gate above — recursive self-improvement with an audit trail, not a claim.
In 2026 a general-purpose research model topped a drug-developability benchmark with no bioinformatics plugin and no fine-tuning. What the reviews said next is the whole thesis of this company.
GPT-6 Astra placed first on Insilico Medicine's DDD antibody-developability benchmark (37.98) — no plugins, no fine-tuning — while general biomedical agents (Biomni, DrugAgent) closed in on expert baselines. Generation is no longer the scarce input.
Practitioner reviews of these agents converge on one failure mode: they are "prone to plausible-but-wrong outputs, weak guardrails." The prescription is explicit — a held-out benchmark + quantified uncertainty + a human checkpoint.
That prescription is SwarmLabs. We do not compete to out-predict the frontier model; we are the layer that says whether a given prediction can be trusted. The stronger the base model, the more that layer is worth.
And it is callable, not a slide. The engine is exposed as an MCP server (verify_prediction → PROCEED / BLOCK_AUTONOMOUS_ACTION) and as a read-only HTTP gate (GET /v3/gate/{key}) any agent can query without running Python. Confidence below the calibrated threshold returns an explicit block — never a confident guess.
Honest positioning: we are not "another AI science assistant". We are the verification substrate beneath them.
| Dimension | Chat-based AI science tools | SwarmLabs |
|---|---|---|
| Core value | Read / write / summarize the literature | Replace real experiments (GP surrogate + UQ + virtual experiments) |
| Rigor | Citations & summaries; no quantitative validity proof | 10-chapter V&V report; coverage / κ calibrated against independent sets |
| Uncertainty | No numeric UQ (never answers "how trustworthy is this?") | 3% noise floor never lowered; single-sided coverage verdicts; κ only loosens |
| Reproducibility | Conversation output; hard to archive | 62 reproducibility manifests (seeds / bounds / re-run command) |
| Failures | Systematically filtered / undisclosed | Disclosed — held-out REFUTED cases kept and explained, not hidden |
Everything below is live and machine-readable — please verify rather than take our word for it.
BLOCK_AUTONOMOUS_ACTION, with the uncertainty budget. No Python required.Warm intros, accelerator programs, and strategic collaborations welcome. If you are building AI4S and need a verification substrate, we would like to hear from you.
[email protected]